lycorin
potent
inhibit
flavivirus
cell
cultur
concentr
lycorin
reduc
viral
titer
west
nile
wnv
dengu
yellow
fever
virus
fold
howev
compound
inhibit
alphaviru
western
equin
enceph
viru
rhabdoviru
vesicular
stomat
viru
indic
select
antivir
spectrum
compound
exert
antivir
activ
mainli
suppress
viral
rna
replic
substitut
amino
acid
posit
viral
peptid
span
endoplasm
reticulum
membran
protein
confer
wnv
resist
lycorin
enhanc
viral
rna
replic
initi
chemistri
synthesi
demonstr
modif
two
hydroxyl
group
lycorin
increas
compound
potenc
reduc
cytotox
taken
togeth
result
establish
lycorin
flaviviru
inhibitor
antivir
develop
lycorineresist
result
demonstr
direct
role
peptid
flaviviru
rna
synthesi
famili
flavivirida
consist
three
genera
flavivirus
pestivirus
hepat
c
virus
mani
member
genu
flaviviru
arthropodborn
human
pathogen
includ
four
serotyp
dengu
viru
denv
west
nile
viru
wnv
japanes
enceph
viru
jev
yellow
fever
viru
yfv
tickborn
enceph
viru
tbev
gubler
kuno
markoff
million
human
case
report
annual
denv
yfv
jev
infect
respect
gubler
kuno
markoff
sinc
initi
outbreak
wnv
new
york
viru
caus
thousand
human
case
infect
year
spread
throughout
north
america
kramer
li
shi
effect
antivir
therapi
approv
treatment
flaviviru
infect
human
vaccin
current
avail
jev
yfv
tbev
well
recogn
develop
vaccin
denv
particularli
challeng
need
simultan
immun
four
denv
serotyp
therefor
develop
therapeut
prioriti
intervent
flaviviru
infect
flaviviru
genom
plussens
singlestrand
rna
nucleotid
lindenbach
thiel
rice
genom
rna
consist
untransl
region
utr
singl
open
read
frame
orf
singl
orf
encod
long
polyprotein
cotransl
process
viral
host
proteas
ten
matur
viral
protein
nterminu
polyprotein
contain
three
structur
protein
capsid
c
premembran
prmm
envelop
e
cterminu
polyprotein
contain
seven
nonstructur
ns
protein
complet
cleavag
polyprotein
gener
peptid
peptid
span
membran
endoplasm
reticulum
er
two
viral
protein
enzymat
activ
function
proteas
cofactor
nucleotid
triphosphatas
rna
triphosphatas
helicas
falgout
miller
lai
li
et
al
warren
tamura
collett
wengler
wengler
act
methyltransferas
mtase
rnadependentrna
polymeras
rdrp
ackermann
padmanabhan
egloff
et
al
guyatt
westaway
khromykh
ray
et
al
tan
et
al
besid
function
replic
flavivir
ns
protein
play
role
virion
assembl
jone
patkar
kuhn
kummer
rice
leung
et
al
liu
chen
khromykh
evas
host
innat
immun
respons
best
et
al
guo
hayashi
seeger
liu
et
al
munozjordan
et
al
munozjordan
et
al
upon
viral
entri
nucleocapsid
uncoat
genom
rna
translat
protein
transloc
across
er
membran
form
replic
complex
lindenbach
thiel
rice
molecular
detail
individu
ns
protein
role
flaviviru
replic
remain
character
lycorin
alkaloid
compound
found
sever
plant
daffodil
narcissu
pseudonarcissu
bush
lili
clivia
miniata
number
biolog
activ
report
lycorin
includ
inhibit
protein
dna
synthesi
chattopadhyay
et
al
cell
growth
divis
de
leo
et
al
antileukemia
effect
liu
et
al
liu
et
al
addit
compound
shown
inhibit
polioviru
ieven
et
al
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
li
et
al
herp
simplex
viru
type
renardnozaki
et
al
vaccinia
viru
zhou
et
al
paper
report
lycorin
inhibit
flavivirus
select
antivir
spectrum
modeofact
analysi
indic
lycorin
inhibit
flavivirus
mainli
suppress
viral
rna
synthesi
structur
modif
lycorin
compound
increas
potenc
decreas
cytotox
indic
potenti
compound
therapeut
develop
furthermor
found
singleamino
acid
substitut
wnv
peptid
confer
resist
lycorin
partial
enhanc
viral
rna
synthesi
thu
reveal
direct
role
peptid
flaviviru
rna
replic
lycorin
fig
report
antivir
activ
see
introduct
test
whether
lycorin
inhibit
flavivirus
initi
screen
compound
use
virallik
particl
vlp
base
infect
assay
depict
figur
vlp
wnv
prepar
transsuppli
viral
structur
protein
cprme
alphaviru
semliki
forest
viru
sfv
express
vector
packag
correspond
replicon
rna
contain
luciferas
report
titer
vlp
estim
ffuml
wnv
respect
vero
cell
infect
ffucel
wnv
vlp
ffucel
vlp
due
low
titer
vlp
infect
cell
treat
lycorin
mocktreat
dmso
h
postinfect
pi
lycorin
reduc
luciferas
signal
wnv
vlpinfect
cell
respect
fig
higher
concentr
lycorin
also
test
howev
due
cytotox
result
present
see
next
section
result
indic
lycorin
inhibit
wnv
perform
mtt
assay
determin
cytotox
lycorin
order
exclud
possibl
abovedescrib
antivir
activ
due
compoundmedi
cytotox
fig
vero
cell
incub
variou
concentr
lycorin
h
cell
viabil
indic
cellular
metabol
mtt
tetrazolium
salt
cc
cytotox
concentr
valu
compound
estim
cell
viabil
therefor
follow
experi
perform
lycorin
next
assay
antivir
activ
lycorin
use
authent
wnv
infect
assay
vero
cell
infect
epidem
strain
wnv
moi
infect
treat
variou
concentr
compound
assay
viral
yield
cultur
medium
h
pi
fig
compound
suppress
viral
titer
doserespons
manner
compound
reduc
viral
titer
ec
effect
concentr
valu
estim
result
demonstr
lycorin
inhibit
wnv
noncytotox
concentr
examin
antivir
spectrum
lycorin
perform
viral
titer
reduct
assay
use
flavivirus
yfv
plusstrand
rna
alphaviru
western
equin
enceph
viru
weev
negativestrand
rna
rhabdoviru
vesicular
stomat
viru
vsv
lycorin
inhibit
yfv
fig
compound
reduc
viral
titer
yfv
respect
contrast
compound
suppress
titer
neither
weev
vsv
test
concentr
latter
result
suggest
lycorin
cytotox
overal
result
indic
antivir
spectrum
compound
select
flavivirus
given
lycorin
inhibit
vlpmediat
infect
fig
compound
could
block
step
viral
entri
andor
replic
pinpoint
step
compound
inhibit
test
compound
vero
cell
line
contain
persist
replic
replicon
wnv
denv
rlucneorep
fig
incub
rlucneorep
cell
lycorin
h
h
led
reduc
luciferas
activ
suggest
compound
inhibit
viral
translat
andor
rna
synthesi
use
transient
replicon
system
fig
differenti
inhibit
viral
translat
inhibit
rna
synthesi
previou
studi
show
transfect
cell
wnv
produc
two
luciferas
peak
one
h
posttransfect
pt
anoth
h
pt
respect
repres
viral
translat
rna
replic
puigbasago
et
al
shown
figur
wherea
lycorin
suppress
earli
luciferas
signal
h
pt
reduc
late
luciferas
signal
h
pt
taken
togeth
result
suggest
lycorin
weakli
inhibit
viral
translat
strongli
suppress
rna
synthesi
timeofaddit
experi
perform
elucid
modeofact
lycorin
fig
vero
cell
synchron
infect
wnv
puigbasago
et
al
lycorin
ad
infect
cell
variou
time
point
postinfect
viral
titer
cultur
medium
determin
h
postinfect
control
dmso
ad
infect
cell
h
pi
estim
effect
viral
yield
result
show
inhibitori
effect
lycorin
viral
titer
gradual
diminish
compound
ad
time
point
h
pi
compound
complet
lost
antivir
activ
ad
h
postinfect
result
agre
transient
replicon
result
indic
lycorin
weakli
inhibit
viral
translat
strongli
suppress
rna
synthesi
identifi
potenti
antivir
target
directli
test
lycorin
previous
establish
enzym
assay
use
recombin
protein
wnv
includ
proteas
ntpase
mtase
rdrp
ray
et
al
wong
et
al
none
enzym
activ
suppress
compound
concentr
data
shown
result
suggest
compound
directli
target
enzym
function
viral
protein
altern
mean
identifi
antivir
target
select
lycorineresist
wnv
cultur
wildtyp
wt
viru
presenc
increas
concentr
compound
fig
three
independ
select
iiii
perform
select
total
passag
carri
first
passag
select
lycorin
last
passag
select
lycorin
virus
passag
assay
resist
comparison
viral
titer
mocktreat
infect
viral
titer
lycorinetr
infect
harvest
h
pi
figur
show
repres
data
resist
assay
viral
resist
gradual
improv
improv
observ
fig
data
shown
therefor
termin
select
notabl
virus
show
complet
resist
lycorin
compound
reduc
viral
titer
virusinfect
cell
approxim
contrast
compound
suppress
viral
titer
wt
virusinfect
cell
concentr
fig
result
indic
resist
virus
increas
approxim
wt
similar
result
obtain
three
independ
select
plaqu
morpholog
wt
lycorineresist
virus
compar
agar
contain
lycorin
fig
plaqu
deriv
virus
slightli
heterogen
size
plaqu
deriv
wt
viru
indic
virus
compos
quasispeci
howev
major
plaqu
virus
similar
size
plaqu
deriv
wt
viru
collect
result
demonstr
wnv
partial
resist
lycorin
reproduc
select
cell
cultur
complet
genom
virus
three
independ
select
sequenc
identifi
potenti
resist
mutat
perform
popul
sequenc
directli
sequenc
rtpcr
product
amplifi
rna
extract
cultur
supernat
fig
select
accumul
consensu
nucleotid
chang
g
posit
result
amino
acid
substitut
val
met
posit
peptid
mutat
detect
select
iii
select
ii
two
addit
distinct
nucleotid
mutat
recov
e
gene
one
mutat
silent
one
led
aminoacid
chang
fig
sequenc
chromatogram
indic
e
mutat
exist
mix
popul
repres
wt
mutant
nucleotid
peak
specif
posit
data
shown
neg
control
virus
passag
dmso
give
rise
mutat
prepar
two
panel
recombin
virus
identifi
lycorineresist
determin
first
panel
virus
contain
mutat
e
gene
four
mutat
e
region
individu
engin
infecti
cdna
clone
wnv
transfect
cell
genomelength
rna
result
four
mutant
virus
fig
deriv
select
deriv
select
ii
four
mutant
virus
exhibit
differ
plaqu
morpholog
two
virus
contain
silent
mutat
yield
plaqu
similar
wt
viru
wherea
mutant
virus
contain
amino
acid
chang
e
protein
gener
smaller
plaqu
wt
viru
resist
assay
show
treatment
infect
cell
moi
lycorin
lycorin
h
none
four
mutant
yield
viral
titer
significantli
higher
titer
wt
viru
fig
result
indic
e
mutat
respons
resist
notabl
smaller
plaqu
fig
lower
titer
mocktreat
infect
mutant
virus
fig
suggest
amino
acid
chang
e
gene
neg
affect
viral
replic
second
panel
virus
prepar
examin
mutat
peptid
plaqu
morpholog
viru
similar
wt
viru
fig
remark
viru
show
resist
level
close
virus
three
select
fig
sequenc
mutant
viru
indic
engin
mutat
retain
without
extra
chang
furthermor
mutat
retain
passag
mutant
viru
vero
cell
five
round
total
day
data
shown
result
demonstr
mutat
peptid
major
determin
lycorin
resist
sequenc
align
fig
indic
mutat
val
aminoacid
posit
peptid
total
amino
acid
conserv
among
member
jevserocomplex
val
posit
conserv
among
member
denvserocomplex
wherea
val
found
similar
posit
peptid
member
yfvand
tbevserocomplex
character
mutat
compar
replic
kinet
wt
mutant
mt
virus
presenc
absenc
lycorin
inhibitor
vero
cell
synchron
infect
wt
mt
virus
treat
without
lycorin
expect
compound
inhibit
wt
viru
dramat
mt
viru
fig
western
blot
analysi
show
h
pi
viral
protein
could
detect
cell
infect
either
wt
mutant
virus
data
shown
express
level
viral
increas
h
pi
decreas
h
pi
decreas
protein
express
h
pi
due
cytopath
effect
ie
cell
lysi
time
point
lycorin
treatment
suppress
viral
protein
express
result
confirm
critic
role
mutat
lycorin
resist
valid
contribut
chang
resist
engin
mutat
report
replicon
wnv
absenc
lycorin
mutant
wt
replicon
yield
equal
level
luciferas
activ
h
pt
contrast
mutant
replicon
exhibit
luciferas
signal
higher
wt
replicon
h
pt
respect
fig
result
demonstr
peptid
mutat
affect
viral
translat
instead
enhanc
rna
synthesi
especi
earli
replic
stage
presenc
inhibitor
luciferas
signal
wt
mutant
replicon
reduc
report
signal
h
pt
slightli
suppress
replicon
howev
luciferas
activ
h
pt
wt
replicon
dramat
suppress
compound
activ
mutant
replicon
result
demonstr
singleamino
acid
chang
peptid
respons
lycorin
resist
examin
effect
mutat
peptid
viral
replic
compar
growth
kinet
wt
mutant
virus
vero
mosquito
cell
infect
wt
mutant
viru
moi
monitor
viral
yield
vero
cell
mutant
viru
produc
titer
higher
wt
viru
h
pi
respect
differ
viral
titer
reduc
h
pi
fig
cell
mutant
viru
gener
titer
higher
wt
viru
test
time
point
vero
cell
similar
titer
wt
mutant
virus
detect
h
pi
low
viral
titer
like
deriv
input
virus
inocul
substanti
compos
progeni
virus
result
togeth
transient
replicon
data
fig
strongli
indic
peptid
mutat
enhanc
viral
replic
note
replic
enhanc
evid
plaqu
size
compar
wt
mutant
virus
fig
initi
chemistri
studi
synthes
seven
lycorin
analogu
tabl
analogu
examin
cytotox
antivir
activ
three
region
parent
lycorin
compound
modifi
one
two
hydroxyl
group
posit
lycorin
substitut
chemic
group
seven
analogu
contain
modif
show
cc
valu
higher
valu
parent
lycorin
among
compound
hydroxyl
group
acetyl
hydroxyl
group
oxid
form
carbonyl
group
slightli
increas
potenc
ec
significantli
reduc
cytotox
cc
highest
test
concentr
expect
mutant
viru
resist
compound
data
shown
ii
pyrrolidin
ring
lycorin
open
iii
lycorin
oxid
carbonyl
group
compound
compound
ii
iii
modif
lower
antivir
potenc
result
clearli
indic
modif
two
hydroxyl
group
lycorin
could
use
improv
antivir
profil
number
approach
report
develop
flaviviru
antivir
agent
shi
goal
studi
establish
antiflaviviru
activ
lycorin
analyz
lycorineresist
flaviviru
cell
cultur
previou
studi
show
lycorin
inhibit
polioviru
ieven
et
al
sarscov
li
et
al
herp
simplex
viru
renardnozaki
et
al
vaccinia
viru
zhou
et
al
current
studi
extend
antivir
spectrum
flavivirus
addit
show
lycorin
inhibit
alphaviru
weev
rhabdoviru
vsv
fig
latter
result
togeth
find
earli
studi
show
lycorin
inhibit
noncytotox
concentr
szlavik
et
al
indic
select
antivir
spectrum
compound
proofofprincipl
show
modif
lycorin
compound
especi
two
hydroxyl
group
could
dramat
reduc
cytotox
improv
potenc
tabl
result
suggest
lycorin
repres
one
class
inhibitor
could
potenti
develop
flaviviru
therapeut
three
wnv
luciferasereport
repliconbas
assay
use
dissect
inhibitori
step
lycorin
first
vlpinfectionbas
assay
allow
identif
inhibitor
viral
entri
replic
fig
second
use
repliconcontain
cell
line
allow
screen
inhibitor
viral
replic
fig
third
transient
replicon
assay
allow
differenti
inhibitor
translat
inhibitor
rna
synthesi
fig
analysi
compound
system
indic
wherea
lycorin
weakli
reduc
viral
translat
indic
luciferas
activ
significantli
suppress
rna
synthesi
indic
luciferas
activ
reduct
rna
synthesi
could
caus
compoundmedi
suppress
viral
translat
altern
lycorin
could
suppress
translat
rna
synthesi
lead
dramat
reduct
rna
synthesi
differenti
two
possibl
perform
timeofaddit
experi
result
show
lycorin
gradual
declin
antiwnv
activ
time
addit
vari
h
pi
compound
complet
lost
inhibitori
activ
ad
pi
fig
singl
round
flaviviru
infect
h
durat
viral
translat
peak
around
h
pi
rna
synthesi
peak
around
h
pi
chamber
et
al
puigbasago
et
al
lycorin
inhibit
step
translat
would
complet
lost
antivir
activ
ad
time
point
earlier
h
pi
ie
h
pi
therefor
timeofaddit
result
clearli
indic
compound
inhibit
step
beyond
viral
translat
data
togeth
identif
resist
determin
peptid
fig
led
us
conclud
lycorin
suppress
wnv
mainli
suppress
viral
rna
synthesi
data
contrast
polioviru
result
indic
viral
translat
suppress
equival
lycorin
ieven
et
al
sinc
cytotox
lycorin
shown
polioviru
studi
experi
need
exclud
possibl
strong
inhibit
viral
translat
due
compoundmedi
cytotox
perform
modeofact
analysi
lycorin
concentr
allow
cell
viabil
system
lycorin
decreas
viabil
vero
cell
fig
two
approach
taken
identifi
potenti
viral
target
lycorin
first
approach
test
compound
biochem
enzym
assay
use
recombin
proteas
ntpase
rdrp
mtase
protein
none
enzym
activ
suppress
lycorin
second
approach
select
compoundresist
wnv
select
resist
wnv
cell
cultur
engin
mutat
recov
resist
virus
infecti
clone
fig
replicon
fig
wnv
allow
us
map
resist
determin
singl
aminoacid
chang
peptid
note
resist
result
necessarili
indic
peptid
direct
target
lycorin
peptid
mutat
could
exert
resist
phenotyp
enhanc
viral
replic
presenc
inhibitor
viral
replic
could
still
sustain
level
suffici
gener
viru
latter
scenario
support
observ
peptid
mutat
enhanc
rna
synthesi
wnv
replicon
well
growth
kinet
wnv
vero
cell
fig
howev
point
mutationmedi
enhanc
viral
replic
partial
contribut
lycorin
resist
latter
conclus
support
result
mutat
increas
replic
absenc
lycorin
fig
wherea
mutat
increas
replic
presenc
inhibitor
fig
peptid
mutat
enhanc
wnv
rna
replic
flaviviru
peptid
span
er
membran
nand
ctermin
tail
cytoplasm
er
lumen
side
respect
miller
et
al
cleavag
junction
host
signalas
requir
prior
cleavag
junction
viral
proteas
lin
et
al
regul
cleavag
site
play
role
rearrang
cytoplasm
membran
miller
et
al
roosenda
et
al
exact
function
peptid
induct
membran
arrang
may
differ
among
flavivirus
kunv
individu
express
result
membran
rearrang
resembl
virusinduc
structur
remov
domain
led
less
profound
membran
rearrang
roosenda
et
al
contrast
express
without
peptid
result
alter
membran
resembl
virusinduc
structur
wherea
express
induc
compar
membran
arrang
miller
et
al
sinc
rearrang
membran
form
scaffold
viral
replic
complex
mutat
may
affect
peptidemedi
membran
alter
lead
increas
rna
replic
altern
sinc
cleavag
intermedi
critic
inhibit
interferon
signal
munozjordan
et
al
mutat
peptid
may
affect
process
polyprotein
result
effici
defens
host
immun
respons
weaken
interferon
respons
allow
viru
replic
higher
level
hypothesi
support
observ
peptid
mutat
recov
wnv
abl
perform
superinfect
zhang
shi
unpublish
data
later
studi
found
peptid
mutant
viru
show
significantli
improv
capabl
replic
cell
contain
persist
replic
replicon
wnv
one
caveat
hypothesi
lycorin
resist
studi
perform
vero
cell
interferon
gene
delet
mosca
pitha
experi
requir
dissect
molecular
mechan
peptid
oper
flaviviru
replic
evas
host
immun
respons
babi
hamster
kidney
cell
african
green
monkey
kidney
cell
vero
cultur
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
co
aed
albopictu
cell
grown
eagl
minim
essenti
medium
emem
fb
nonessenti
amino
acid
report
vero
cell
line
contain
persist
replic
wnv
replicon
rlucneorep
fig
cultur
dmem
fb
mgml
wnv
deriv
fulllength
infecti
cdna
clone
epidem
strain
yfv
vaccin
strain
new
guinea
c
strain
weev
strain
cova
vsv
new
jersey
serotyp
use
antivir
assay
describ
previous
puigbasago
et
al
lycorin
purchas
biomol
research
laboratori
inc
panel
seven
lycorin
analogu
tabl
synthes
base
previou
methodolog
compound
lee
et
al
nakagawa
uyeo
yajima
lee
et
al
lee
et
al
shu
et
al
nakagawa
uyeo
yajima
method
synthesi
compound
describ
elsewher
structur
puriti
compound
establish
nuclear
magnet
reson
compound
dissolv
dimethyl
sulfoxid
dmso
test
dmso
final
concentr
mocktreat
reaction
incub
dmso
without
lycorin
analogu
vlp
wnv
prepar
transsuppli
viral
structur
protein
replicon
rna
replicon
contain
renilla
luciferas
rluc
footandmouth
diseas
viru
sequenc
posit
viral
structur
gene
cprme
delet
fig
construct
character
wnv
report
previous
puigbasago
et
al
structur
gene
viru
clone
sfv
express
vector
invitrogen
liljestrom
garoff
uniqu
bam
hi
site
result
sfvcprme
fig
kozak
sequenc
stop
codon
engin
end
cprme
fragment
respect
doubletransfect
protocol
use
gener
vlp
khromykh
varnavski
westaway
puigbasago
et
al
briefli
cell
first
electropor
rna
cuvett
genepuls
apparatu
biorad
use
set
kv
puls
three
time
interv
transfect
cell
resuspend
dmem
fb
incub
co
h
replicontransfect
cell
electropor
sfvcprme
rna
correspond
viru
set
ident
use
first
transfect
h
second
transfect
cultur
supernat
collect
centrifug
remov
cellular
debri
vlp
supernat
aliquot
store
titer
vlp
focusform
unit
ffu
ml
estim
infect
vero
cell
fourchamb
labtek
chamber
slide
nalg
nunc
intern
serial
dilut
cultur
fluid
follow
count
immunofluoresc
assay
ifa
posit
cell
foci
h
pi
wnv
respect
ifa
immun
mous
ascit
fluid
wnv
american
type
cultur
collect
goat
antimous
immunoglobulin
g
conjug
texa
red
use
primari
secondari
antibodi
respect
vlpbase
antivir
assay
monolay
naiv
vero
cell
cell
per
well
plate
infect
ffucel
wnv
vlp
ffucel
vlp
lycorin
immedi
ad
vlpinfect
cell
h
pi
cell
wash
twice
cold
pb
lyse
renilla
luciferas
lysi
buffer
min
assay
luciferas
activ
use
renilla
luciferas
assay
kit
promega
luciferas
signal
measur
verita
micropl
luminomet
promega
averag
result
three
independ
experi
present
vero
cell
contain
persist
replic
replicon
wnv
puigbasago
et
al
construct
previous
replicon
contain
two
report
gene
renilla
luciferas
rluc
neomycin
phosphotransferas
gene
neo
result
rlucneorep
fig
antivir
assay
rlucneorepcontain
vero
cell
seed
per
well
plate
dmem
fb
without
lycorin
ad
medium
h
postseed
h
lycorinetreat
cell
lyse
assay
luciferas
activ
describ
transient
replicon
assay
use
quantifi
compoundmedi
inhibit
viral
translat
suppress
rna
synthesi
briefli
rna
wnv
fig
electropor
cell
describ
transfect
cell
suspend
ml
dmem
fb
cell
suspens
ml
seed
plate
immedi
treat
lycorin
assay
luciferas
activ
h
pt
repres
viral
translat
h
pt
repres
rna
synthesi
quantif
compoundmedi
inhibit
rel
luciferas
activ
present
luciferas
activ
deriv
mocktreat
cell
set
viral
titer
reduct
assay
perform
examin
antivir
activ
lycorin
analogu
wnv
yfv
weev
vsv
approxim
vero
cell
per
well
seed
plate
incub
h
cell
infect
individu
viru
moi
treat
immedi
one
compound
indic
concentr
wnv
yfv
weev
sampl
cultur
medium
collect
h
postinfect
vsv
cultur
medium
collect
h
postinfect
collect
sampl
store
viral
titer
determin
plaqu
assay
vero
cell
doubleoverlay
protocol
follow
plaqu
assay
puigbasago
et
al
assay
perform
triplic
cytotox
compound
examin
use
cell
proliferationbas
mtt
assay
american
type
cultur
collect
describ
previous
puigbasago
et
al
three
independ
lineag
lycorineresist
wnv
gener
passag
wt
wnv
deriv
infecti
cdna
clone
vero
cell
increas
concentr
lycorin
first
six
passag
vero
cell
plate
infect
wnv
deriv
time
previou
passag
moi
presenc
lycorin
dmso
neg
control
passag
select
lycorin
passag
viral
supernat
harvest
h
pi
viral
titer
quantifi
plaqu
assay
virus
analyz
resist
assay
monitor
improv
resist
comparison
viral
titer
lycorinetr
infect
viral
titer
mocktreat
infect
select
termin
passag
improv
resist
observ
see
detail
result
lycorineresist
wnv
passag
subject
genomelength
sequenc
identif
accumul
mutat
virion
rna
extract
cultur
supernat
use
rneasi
kit
qiagen
viral
rna
amplifi
rtpcr
use
superscript
iii
onestep
rtpcr
kit
invitrogen
pcr
product
gelpurifi
subject
dna
sequenc
sequenc
nucleotid
viral
genom
determin
rapid
amplif
cdna
end
race
perform
use
firstchoic
rlmrace
kit
ambion
perform
previous
describ
tilgner
shi
wnv
genomelength
cdna
clone
specif
mutat
construct
use
modifi
pflwnv
two
shuttl
vector
shuttl
vector
construct
engin
bam
hisph
fragment
pflwnv
repres
upstream
end
promot
rna
transcript
genomelength
rna
nucleotid
posit
wnv
genom
genbank
vector
contain
modifi
clone
cassett
zhou
et
al
quikchang
ii
xl
sitedirect
mutagenesi
kit
stratagen
use
engin
mutat
e
gene
shuttl
vector
mutat
dna
fragment
cutandpast
back
pflwnv
clone
bam
hi
stu
site
nucleotid
posit
shuttl
vector
b
construct
engin
kpn
ixba
fragment
repres
nucleotid
end
genom
vector
mutat
engin
shuttl
vector
b
use
quikchang
ii
xl
sitedirect
mutagenesi
kit
mutat
dna
fragment
past
back
pflwnv
clone
cdna
clone
wnv
replicon
bsi
wi
spe
site
nucleotid
posit
construct
verifi
dna
sequenc
genomelength
rna
replicon
rna
vitro
transcrib
correspond
cdna
plasmid
linear
xba
mmessag
mmachin
kit
ambion
use
rna
synthesi
describ
replicon
genomelength
rna
electropor
cell
describ
transfect
genomelength
rna
cultur
fluid
collect
everi
h
appar
cytopath
effect
observ
day
day
posttransfect
virus
supernat
aliquot
store
zhou
ray
zhao
dong
h
ren
li
z
guo
bernard
k
shi
p
li
h
ad
infect
cell
h
pi
estim
effect
viral
product
replic
kinet
wt
virus
presenc
absenc
lycorin
vero
cell
plate
infect
wnv
wt
mt
moi
incub
h
wash
three
time
pb
incub
medium
contain
lycorin
medium
contain
dmso
h
pi
viral
titer
supernat
determin
plaqu
assay
infect
cell
wash
twice
pb
lyse
lysi
buffer
frozen
cell
lysat
analyz
western
blot
b
four
monoclon
antibodi
dilut
purchas
sigma
dilut
inhous
gener
dilut
inhous
gener
dilut
purchas
sigma
mix
use
primari
antibodi
hors
radish
peroxidas
hrp
label
antimous
igg
dilut
use
secondari
antibodi
use
load
control
one
repres
two
experi
shown
virus
moi
incub
cell
wash
three
time
pb
medium
replenish
viral
titer
cultur
fluid
quantifi
indic
time
point
use
plaqu
assay
